Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 7 (2007), Pages 1375-1392
http://dx.doi.org/10.1100/tsw.2007.185
Review Article

Cysteinyl-Leukotriene Receptors and Cellular Signals

Laboratory of Molecular Pharmacology, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy

Received 22 January 2007; Revised 1 June 2007; Accepted 2 July 2007

Academic Editor: Charles Brink

Copyright © 2007 G. Enrico Rovati and Valérie Capra.

Citations to this Article [39 citations]

The following is the list of published articles that have cited the current article.

  • Magnus Back, “Leukotriene receptors: Crucial components in vascular inflammation,” Thescientificworldjournal, vol. 7, pp. 1422–1439, 2007. View at Publisher · View at Google Scholar
  • Kasem Nithipatikom, and William B Campbell, “Roles of eicosanoids in prostate cancer,” Future Lipidology, vol. 3, no. 4, pp. 453–467, 2008. View at Publisher · View at Google Scholar
  • Hideaki Shirasaki, “Cysteinyl leukotriene receptor CysLT(1) as a novel therapeutic target for allergic rhinitis treatment,” Expert Opinion On Therapeutic Targets, vol. 12, no. 4, pp. 415–423, 2008. View at Publisher · View at Google Scholar
  • Nina Wettschureck, “G protein alpha q,” AfCS-Nature Molecule Pages, 2009. View at Publisher · View at Google Scholar
  • Matthew W. Buczynski, Darren S. Dumlao, and Edward A. Dennis, “An integrated omics analysis of eicosanoid biology,” Journal of Lipid Research, vol. 50, no. 6, pp. 1015–1038, 2009. View at Publisher · View at Google Scholar
  • Daisy T. Joo, and Gail K. Wong, “Drug interactions: lipoxygenase inhibitors interfere with ropivacaine-induced vasoconstriction,” Canadian Journal Of Anaesthesia-Journal Canadien D Anesthesie, vol. 56, no. 4, pp. 279–283, 2009. View at Publisher · View at Google Scholar
  • Necat Biber, Hale Z. Toklu, Seyhun Solakoglu, Mine Gultomruk, Tayfun Hakan, Zafer Berkman, and F. Gul Dulger, “Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury,” Brain Injury, vol. 23, no. 6, pp. 577–584, 2009. View at Publisher · View at Google Scholar
  • Josiane S. Neves, Amy L. Radke, and Peter F. Weller, “Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules,” Journal Of Allergy And Clinical Immunology, vol. 125, no. 2, pp. 477–482, 2010. View at Publisher · View at Google Scholar
  • L. Xu, L. Zhang, L. Liu, S. Fang, Y. Lu, E. Wei, and W. Zhang, “Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings,” Pharmazie, vol. 65, no. 10, pp. 750–754, 2010. View at Publisher · View at Google Scholar
  • R. K. Singh, S. Gupta, S. Dastidar, and A. Ray, “Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics,” Pharmacology, vol. 85, no. 6, pp. 336–349, 2010. View at Publisher · View at Google Scholar
  • Graziano Riccioni, Magnus Bäck, and Valérie Capra, “Leukotrienes and atherosclerosis,” Current Drug Targets, vol. 11, no. 7, pp. 882–887, 2010. View at Publisher · View at Google Scholar
  • Magnus Back, Sven-Erik Dahlen, Jeffrey M. Drazen, Jilly F. Evans, Charles N. Serhan, Takao Shimizu, Takehiko Yokomizo, and G. Enrico Rovati, “International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions,” Pharmacological Reviews, vol. 63, no. 3, pp. 539–584, 2011. View at Publisher · View at Google Scholar
  • Wendy Ka-hoi Lau, Alison Wai-ming Chow, Simon Chak-leung Au, and Wing-hung Ko, “Differential Inhibitory Effects of CysLT(1) Receptor Antagonists on P2Y(6) Receptor-Mediated Signaling and Ion Transport in Human Bronchial Epithelia,” Plos One, vol. 6, no. 7, 2011. View at Publisher · View at Google Scholar
  • Jan N. Hilberath, Troy Carlo, Michael A. Pfeffer, Roxanne H. Croze, Frantz Hastrup, and Bruce D. Levy, “Resolution of Toll-like receptor 4-mediated acute lung injury is linked to eicosanoids and suppressor of cytokine signaling 3,” Faseb Journal, vol. 25, no. 6, pp. 1827–1835, 2011. View at Publisher · View at Google Scholar
  • Ilaria Bettinelli, Davide Graziani, Cristina Marconi, Alessandro Pedretti, and Giulio Vistoli, “The Approach of Conformational Chimeras to Model the Role of Proline-Containing Helices on GPCR Mobility: the Fertile Case of Cys-LTR1,” ChemMedChem, vol. 6, no. 7, pp. 1217–1227, 2011. View at Publisher · View at Google Scholar
  • S. Poulin, C. Thompson, M. Thivierge, S. Veronneau, S. McMahon, C. M. Dubois, J. Stankova, and M. Rola-Pleszczynski, “Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells,” Clinical And Experimental Allergy, vol. 41, no. 2, pp. 204–217, 2011. View at Publisher · View at Google Scholar
  • Ariane Brochu-Bourque, Steeve Veronneau, Marek Rola-Pleszczynski, and Jana Stankova, “Differential Signaling Defects Associated with the M201V Polymorphism in the Cysteinyl Leukotriene Type 2 Receptor,” Journal Of Pharmacology And Experimental Therapeutics, vol. 336, no. 2, pp. 431–439, 2011. View at Publisher · View at Google Scholar
  • Chiara Carnini, Maria Rosa Accomazzo, Emanuele Borroni, Laura Vitellaro-Zuccarello, Thierry Durand, Giancarlo Folco, G. Enrico Rovati, Valerie Capra, and Angelo Sala, “Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT(2) receptor,” Faseb Journal, vol. 25, no. 10, pp. 3519–3528, 2011. View at Publisher · View at Google Scholar
  • Joseph J. Wakshlag, Jeanine Peters-Kennedy, Jennifer J. Bushey, and John P. Loftus, “5-lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats,” American Journal of Veterinary Research, vol. 72, no. 10, pp. 1369–1377, 2011. View at Publisher · View at Google Scholar
  • Chiko Shimbori, Naotaka Shiota, and Hideki Okunishi, “Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice,” European Journal of Pharmacology, vol. 650, no. 1, pp. 424–430, 2011. View at Publisher · View at Google Scholar
  • Masato Muraki, Shu Imbe, Hiroshi Santo, Ryuji Sato, Hiroyuki Sano, Takashi Iwanaga, and Yuji Tohda, “Effects of a Cysteinyl Leukotriene Dual 1/2 Receptor Antagonist on Antigen-Induced Airway Hypersensitivity and Airway Inflammation in a Guinea Pig Asthma Model,” International Archives of Allergy and Immunology, vol. 155, no. s1, pp. 90–95, 2011. View at Publisher · View at Google Scholar
  • Xue-Qin Huang, Xia-Yan Zhang, Xiao-Rong Wang, Shu-Ying Yu, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang, and Er-Qing Wei, “Transforming growth factor beta 1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1,” Journal Of Neuroinflammation, vol. 9, 2012. View at Publisher · View at Google Scholar
  • Valérie Capra, Magnus Bäck, Silvia S. Barbieri, Marina Camera, Elena Tremoli, and G. Enrico Rovati, “Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke,” Medicinal Research Reviews, vol. 33, no. 2, pp. 364–438, 2012. View at Publisher · View at Google Scholar
  • Sujoy Khan, and Nuala Lynch, “Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria,” Inflammation and Allergy - Drug Targets, vol. 11, no. 3, pp. 235–243, 2012. View at Publisher · View at Google Scholar
  • Alexandre P. Rogerio, and Fernanda F. Anibal, “Role of Leukotrienes on Protozoan and Helminth Infections,” Mediators of Inflammation, vol. 2012, pp. 1–13, 2012. View at Publisher · View at Google Scholar
  • Xia-Yan Zhang, Wei-Ping Zhang, Er-Qing Wei, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, and Yun-Bi Lu, “HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 2, pp. 328–341, 2013. View at Publisher · View at Google Scholar
  • Rakesh kumar Singh, Ruchi Tandon, Sunanda Ghosh Dastidar, and Abhijit Ray, “A Review on Leukotrienes and Their Receptors with Reference to Asthma,” Journal of Asthma, pp. 1–32, 2013. View at Publisher · View at Google Scholar
  • Gökhan Koca, Salih S. Gültekin, Ünsal Han, Serdar Kuru, Koray Demirel, and Meliha Korkmaz, “The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats,” Nuclear Medicine Communications, vol. 34, no. 5, pp. 507–517, 2013. View at Publisher · View at Google Scholar
  • Sune T. Jørgensen, Heidi N. Eriksen, Janni Dausell, Thomas Jespersen, Ian H. Lambert, and Else K. Hoffmann, “Double mutation at the putative protein kinase C phosphorylation sites thr plus Thr323 in the mouse leukotrieneD4 receptor eliminates homologous desensitization,” Cellular Physiology and Biochemistry, vol. 31, no. 2-3, pp. 366–378, 2013. View at Publisher · View at Google Scholar
  • Claudia S. Bitencourt, Valérie L. Bessi, David N. Huynh, Liliane Ménard, Julie S. Lefebvre, Tania Lévesque, Leila Hamdan, Fanny Sohouhenou, Lucia H. Faccioli, Pierre Borgeat, and Sylvie Marleau, “Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury,” Journal of Cellular and Molecular Medicine, 2013. View at Publisher · View at Google Scholar
  • Rossella Pecoraro, Giuseppe Fabio Parisi, Angela Lanzafame, Antonio Trovato, Salvatore Leonardi, and Patrizia Barone, “Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children?,” Journal of Pediatric Biochemistry, vol. 3, no. 4, pp. 203–211, 2013. View at Publisher · View at Google Scholar
  • Sujoy Khan, Anirban Maitra, Pravin Hissaria, Sitesh Roy, Mahesh Padukudru Anand, Nalin Nag, and Harpal Singh, “Chronic Urticaria: Indian Context—Challenges and Treatment Options,” Dermatology Research and Practice, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Rossella Pecoraro, Giuseppe Fabio Parisi, Angela Lanzafame, Antonio Trovato, Patrizia Barone, and Salvatore Leonardi, “Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children,” Journal of Pediatric Biochemistry, vol. 3, no. 4, pp. 203–211, 2013. View at Publisher · View at Google Scholar
  • Xiao-Yan Zhang, Lu Chen, Yi Yang, Dong-Min Xu, Si-Ran Zhang, Chen-Tan Li, Wei Zheng, Shu-Ying Yu, Er-Qing Wei, and Li-Hui Zhang, “Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • Yasir Anwar, Jamal S. M. Sabir, Muhammad I. Qureshi, and Kulvinder S. Saini, “5-Lipoxygenase: A promising drug target against inflammatory diseases-biochemical and pharmacological regulation,” Current Drug Targets, vol. 15, no. 4, pp. 410–422, 2014. View at Publisher · View at Google Scholar
  • Renata Baptista-dos-Reis, Valdirene S. Muniz, and Josiane S. Neves, “Multifaceted Roles of Cysteinyl Leukotrienes in Eliciting Eosinophil Granule Protein Secretion,” BioMed Research International, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Arijit Ghosh, Fang Chen, Abhimanyu Thakur, and Hao Hong, “Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders,” CNS Neuroscience & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Francesca Colazzo, Paolo Gelosa, Elena Tremoli, Luigi Sironi, and Laura Castiglioni, “Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases,” Mediators of Inflammation, vol. 2017, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Junjie Mao, Xiaojun Hu, Pengfei Pang, Bin Zhou, Yaqin Zhang, Dan Li, and Hong Shan, “ Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis ,” PROTEOMICS - Clinical Applications, pp. 1700087, 2018. View at Publisher · View at Google Scholar